Institute for Translational Vaccinology:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Institute for Translational Vaccinology - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9434
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オランダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Institute for Translational Vaccinology (Intravacc) is a nonprofit research and development organization that concentrates on the development of vaccines. The organization’s services include technology transfer, exploratory and clinical research and regulatory support. It also provides novel research and has various development programs on vaccine delivery and formulation. Intravacc’s research and development programs comprise global health, bacterial and viral vaccines, polio center, animal models and 3R research, and vaccine formulation and delivery. The organization conducts research in various areas such as bacterial vaccine technology, viral vaccine technology, novel vaccines and clinical immunology. The organization works in collaboration with pharmaceutical, biotechnology, governments and public institutions to develop novel vaccines. Intravacc is headquartered in Bilthoven, the Netherlands.

Institute for Translational Vaccinology – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Institute for Translational Vaccinology, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Institute for Translational Vaccinology, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Institute for Translational Vaccinology, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Institute for Translational Vaccinology, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Institute for Translational Vaccinology, Medical Devices Deals, 2012 to YTD 2018 9
Institute for Translational Vaccinology, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Institute for Translational Vaccinology, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Expres2ion Biotech and Institute for Translational Vaccinology Enter into Agreement 11
Abera Bioscience Enters into Partnership with Institute for Translational Vaccinology 12
Intravacc And MyLife Technologies Enter Into Co-Development Agreement For Intradermal Vaccination Technology 13
Intravacc Partners with International Vaccine Institute 14
Licensing Agreements 15
Sinovac Biotech Enters Into Licensing Agreement With Intravacc For Sabin Inactivated Polio Vaccine 15
Intravacc Enters into Licensing Agreement with Crucell Holland 16
Intravacc Enters into Licensing Agreement with ViciniVax 17
Institute for Translational Vaccinology – Key Competitors 18
Institute for Translational Vaccinology – Key Employees 19
Institute for Translational Vaccinology – Locations And Subsidiaries 20
Head Office 20
Recent Developments 21
Corporate Communications 21
May 04, 2017: Thijs Veerman CEO at Intravacc 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
Institute for Translational Vaccinology, Pharmaceuticals & Healthcare, Key Facts 2
Institute for Translational Vaccinology, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Institute for Translational Vaccinology, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Institute for Translational Vaccinology, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Institute for Translational Vaccinology, Deals By Therapy Area, 2012 to YTD 2018 8
Institute for Translational Vaccinology, Medical Devices Deals, 2012 to YTD 2018 9
Institute for Translational Vaccinology, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Expres2ion Biotech and Institute for Translational Vaccinology Enter into Agreement 11
Abera Bioscience Enters into Partnership with Institute for Translational Vaccinology 12
Intravacc And MyLife Technologies Enter Into Co-Development Agreement For Intradermal Vaccination Technology 13
Intravacc Partners with International Vaccine Institute 14
Sinovac Biotech Enters Into Licensing Agreement With Intravacc For Sabin Inactivated Polio Vaccine 15
Intravacc Enters into Licensing Agreement with Crucell Holland 16
Intravacc Enters into Licensing Agreement with ViciniVax 17
Institute for Translational Vaccinology, Key Competitors 18
Institute for Translational Vaccinology, Key Employees 19

List of Figures
Institute for Translational Vaccinology, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Institute for Translational Vaccinology, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Institute for Translational Vaccinology, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Institute for Translational Vaccinology, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Institute for Translational Vaccinology, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Institute for Translational Vaccinology, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Institute for Translational Vaccinology, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Institute for Translational Vaccinology, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Institute for Translational Vaccinology, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Institute for Translational Vaccinology:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • CEVA Holdings LLC:戦略・SWOT・企業財務分析
    CEVA Holdings LLC - Strategy, SWOT and Corporate Finance Report Summary CEVA Holdings LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Ballard Power Systems Inc (BLDP):電力:M&Aディール及び事業提携情報
    Summary Ballard Power Systems Inc (Ballard Power) is a clean energy growth company. It designs, develops, manufactures, sells, and services proton exchange membrane (PEM) fuel cell products for power product markets, portable power, and material handling and backup power. The company’s product lines …
  • Cheung Kong Infrastructure Holdings Ltd:企業の戦略・SWOT・財務分析
    Cheung Kong Infrastructure Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Cheung Kong Infrastructure Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • Mapi Pharma Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Mapi Pharma Ltd (Mapi Pharma) is a clinical stage pharmaceutical company that offers development of active pharmaceutical ingredients and formulations, and life cycle management products. The company’s lead products include Glatiramer Acetate Depot, an injection for the treatment of multiple …
  • Agricultural Bank of China Ltd:戦略・SWOT・企業財務分析
    Agricultural Bank of China Ltd - Strategy, SWOT and Corporate Finance Report Summary Agricultural Bank of China Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Matrai Eromu ZRt:企業の戦略的SWOT分析
    Matrai Eromu ZRt - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • AB Orlen Lietuva:企業の戦略的SWOT分析
    AB Orlen Lietuva - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • NEC Corp (6701):企業の財務・戦略的SWOT分析
    NEC Corp (6701) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Mettler-Toledo International Inc:企業の戦略・SWOT・財務分析
    Mettler-Toledo International Inc - Strategy, SWOT and Corporate Finance Report Summary Mettler-Toledo International Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • TreeHouse Foods Inc:企業の戦略・SWOT・財務分析
    TreeHouse Foods Inc - Strategy, SWOT and Corporate Finance Report Summary TreeHouse Foods Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Abu Dhabi Water & Electricity Authority:電力:M&Aディール及び事業提携情報
    Summary Abu Dhabi Water & Electricity Authority (ADWEA) is a government-owned organization provides utility services. The authority researches and develops methods for the production, distribution and consumption of water and electricity efficiently. Through subsidiaries, ADWEA conducts generation, …
  • Vonage Holdings Corp.:戦略・SWOT・企業財務分析
    Vonage Holdings Corp. - Strategy, SWOT and Corporate Finance Report Summary Vonage Holdings Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Slovenske elektrarne, a.s.:発電所・企業SWOT分析
    Slovenske elektrarne, a.s. - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key em …
  • Shandong Airlines Co., Ltd.:企業の戦略・SWOT・財務分析
    Shandong Airlines Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Shandong Airlines Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Telecom Argentina S.A.:戦略・SWOT・企業財務分析
    Telecom Argentina S.A. - Strategy, SWOT and Corporate Finance Report Summary Telecom Argentina S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • ThermoGenesis Holdings Inc (THMO):企業の財務・戦略的SWOT分析
    ThermoGenesis Holdings Inc (THMO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Focus Media Holding Ltd:企業のM&A・事業提携・投資動向
    Focus Media Holding Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Focus Media Holding Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisition …
  • The Wistar Institute-医療機器分野:企業M&A・提携分析
    Summary The Wistar Institute (Wistar) is a biomedical research institute that carries out medical research and training in cancer, infectious diseases, immunology and vaccine development. The institute conducts research on genes, gene expression, and DNA biology; cancer biology; translational resear …
  • HudBay Minerals Inc:企業のM&A・事業提携・投資動向
    HudBay Minerals Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's HudBay Minerals Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …
  • Nu-Med Plus Inc (NUMD):医療機器:M&Aディール及び事業提携情報
    Summary Nu-Med Plus Inc (Nu-Med Plus) is a medical device company. The company offers medical products that deliver therapeutic doses of nitric oxide gas to patients. It provides nitric oxide gas delivery system, portable nitric oxide delivery system and nitric oxide dilution system. Nu-Med Plus’ ni …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆